London Shares - Novartis Shares Slip, Avidity Soars After $12 Billion Biotech Deal
27-10-2025 03:47
LONDON (Reuters) -Shares of Novartis fell 1% on Monday following news of the company's plans to acquire U.S. biotech Avidity Biosciences for about $12 billion, marking the Swiss drugmaker's largest ...
LONDON BROKER RATINGS: Jefferies raises GSK and AstraZeneca to 'buy'
Citigroup cuts Centrica to 'neutral' (buy) - price target 185 pence Jefferies raises GSK to 'buy' (hold) - price target 2,000 (1,450) pence Jefferies raises AstraZeneca to 'buy' (hold) - price target ...
3 UK shares I own for superb passive dividend income
Zaven Boyrazian dives into three UK shares he’s added to his passive income portfolio, with one that’s already doubled its dividend in three years. The post 3 UK shares I own for superb passive ...
London Stock Exchange bouncing back, says metals magnate
The boss of global energy and metals firm Metlen tells the BBC why it moved its primary listing from Athens to London.
Princes Group targeting £1.2bn valuation in London IPO
Food and beverage company Princes Group said on Wednesday that it was targeting a valuation of between around £1.16bn and £1.24bn in its London IPO.
